TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract-Reference-Cited by-同舟云学术

TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract

Published:2006-11-21 Issue:1 Volume:12 Page:73-85
ISSN:1573-675X
Container-title:Apoptosis
language:en
Short-container-title:Apoptosis

Author:

Sadarangani Anil,Kato Sumie,Espinoza Natalia,Lange Soledad,Llados Carmen,Espinosa Marisol,Villalón Manuel,Lipkowitz Stanley,Cuello Mauricio,Owen Gareth I.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Biochemistry, medical,Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s10495-006-0492-z.pdf

Reference50 articles.

1. Marsters SA, Pitti RA, Sheridan JP, Ashkenazi A (1999) Control of apoptosis signalling by Apo2 ligand. Recent Prog Horm Res 54:225–34

2. Gibson SB (2004) Epidermal growth factor and TRAIL interactions in epithelial-derived cells. Vitam Horm 67:207–27

3. Wajant H, Gerspach J, Pfizenmaier K (2005) Tumor therapeutics by design: targeting and activation of death receptors. Cytokine Growth Factor Rev 16:55–6

4. de Thonel A, Eriksson JE (2005) Regulation of death receptors-Relevance in cancer therapies. Toxicol Appl Pharmaco 207:123–32

5. Ling J, Herbst RS, Mendelson DS et al (2006) Apo2L/TRAIL pharmacokinetics in a phase 1a trial in advanced cancer and lymphoma Journal of Clinical Oncology (Meeting Abstracts); ASCO Annual Meeting Proceedings Part I 24: 3047

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS, Redox Regulation, and Anticancer Therapy;Redox Regulation and Therapeutic Approaches in Cancer;2023

2. Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies;Frontiers in Pharmacology;2022-02-16

3. Sensitizing TRAIL response via differential modulation of anti- and pro-apoptotic factors by AZD5582 combined with ER nanosomal TRAIL in neuroblastoma;Acta Histochemica;2022-02

4. Extracellular vesicle-mediated co-delivery of TRAIL and dinaciclib for targeted therapy of resistant tumors;Biomaterials Science;2022

5. Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo;Cancer Biology & Therapy;2021-10-25